MARKET

STTK

STTK

Shattuck Labs, Inc.
NASDAQ
2.970
+0.370
+14.23%
Pre Market: 2.972 +0.002 +0.06% 08:35 12/05 EST
OPEN
2.610
PREV CLOSE
2.600
HIGH
3.000
LOW
2.595
VOLUME
52
TURNOVER
0
52 WEEK HIGH
3.000
52 WEEK LOW
0.6922
MARKET CAP
187.94M
P/E (TTM)
-2.9123
1D
5D
1M
3M
1Y
5Y
1D
Analyst Upgrade Boosts Shattuck On Confidence In Next-Gen Inflammatory Bowel Disease Therapy
Benzinga · 3d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 3d ago
Shattuck Labs Raised to Buy From Neutral by HC Wainwright & Co.
Dow Jones · 4d ago
Shattuck Labs Price Target Announced at $6.00/Share by HC Wainwright & Co.
Dow Jones · 4d ago
HC Wainwright & Co. Upgrades Shattuck Labs to Buy, Announces $6 Price Target
Benzinga · 4d ago
SHATTUCK LABS INC <STTK.O>: H.C. WAINWRIGHT RAISES TO BUY FROM NEUTRAL
Reuters · 4d ago
Shattuck Labs upgraded to Buy from Neutral at H.C. Wainwright
TipRanks · 4d ago
Weekly Report: what happened at STTK last week (1124-1128)?
Weekly Report · 4d ago
More
About STTK
Shattuck Labs, Inc. is a biotechnology company. The Company is engaged in the development of treatments for inflammatory and immune-mediated diseases. Its lead product candidate, SL-325, is a monoclonal antibody that is designed to bind to death receptor 3 (DR3) and inhibit its interaction with its ligand, TL1A. TL1A is a costimulatory ligand in the tumor necrosis factor superfamily, which activates immune responses through binding a single receptor, DR3. The Company is conducting a Phase I clinical trial in healthy volunteers. In addition, the Company is also developing SL-425, a half-life extended version of SL-325. It is also developing multiple preclinical DR3-based bispecific antibodies, which are designed to inhibit both the DR3/TL1A axis and another biologically relevant target for the treatment of patients with inflammatory bowel disease.

Webull offers Shattuck Labs Inc stock information, including NASDAQ: STTK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STTK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STTK stock methods without spending real money on the virtual paper trading platform.